Showing results (11-20 of 30) with videos related to
Sort By:
Pageof 3
Molecular Immunology|June 23, 2009
M-ficolin in the neonatal period: Associations with need for mechanical ventilation and mortality in premature infants with necrotising enterocolitisLuregn J Schlapbach, Ulf Kessler, Steffen Thiel, et al.Molecular Immunology|June 30, 2020
Recruitment of properdin by bi-specific nanobodies activates the alternative pathway of complementDennis V Pedersen, Thies Rösner, Annette G Hansen, et al.Journal of Clinical Immunology|May 3, 2019
Ficolin-3 Deficiency Is Associated with Disease and an Increased Risk of Systemic Lupus ErythematosusAnne Troldborg, Rudi Steffensen, Marten Trendelenburg, et al.Infection and Immunity|November 28, 2012
M-ficolin binds selectively to the capsular polysaccharides of Streptococcus pneumoniae serotypes 19B and 19C and of a Streptococcus mitis strainTroels R Kjaer, Annette G Hansen, Uffe B S Sørensen, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 11, 2017
Analysis of Factor D Isoforms in Malpuech-Michels-Mingarelli-Carnevale Patients Highlights the Role of MASP-3 as a Maturase in the Alternative Pathway of ComplementRasmus Pihl, Lisbeth Jensen, Annette G Hansen, et al.Frontiers in Immunology|August 28, 2020
Functional and Structural Characterization of a Potent C1q Inhibitor Targeting the Classical Pathway of the Complement SystemNick S Laursen, Dennis V Pedersen, Heidi Gytz, et al.Proceedings of the National Academy of Sciences of the United States of America|September 9, 2014
Complement activation by ligand-driven juxtaposition of discrete pattern recognition complexesSøren E Degn, Troels R Kjaer, Rune T Kidmose, et al.Proceedings of the National Academy of Sciences of the United States of America|January 21, 2017
Structure and activation of C1, the complex initiating the classical pathway of the complement cascadeSimon A Mortensen, Bjoern Sander, Rasmus K Jensen, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 23, 2023
Bispecific Complement Engagers for Targeted Complement ActivationDennis V Pedersen, Heidi Gytz, Mikael B L Winkler, et al.Frontiers in Immunology|December 18, 2018
A Single-Domain Antibody Targeting Complement Component C5 Acts as a Selective Inhibitor of the Terminal Pathway of the Complement System and Thus Functionally Mimicks the C-Terminal Domain of the Staphylococcus aureus SSL7 ProteinLaure Yatime, Nicolas S Merle, Annette G Hansen, et al.Pageof 3